IP-W2-R Income Statement - TTM - Inter Pharma Public Company Limited - Equity Right

Income Statement (TTM)

Inter Pharma Public Company Limited - Equity Right Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	408	447	526	626	760	921	1,016	1,226	1,385	1,534	1,739	1,775	1,815	1,799	1,809	1,809	1,807	1,912	1,958	2,051
Change (%)		9.45	17.70	18.98	21.38	21.23	10.35	20.66	12.97	10.76	13.31	2.10	2.23	-0.88	0.55	0.03	-0.13	5.82	2.42	4.73
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	159	183	239	302	404	508	570	723	821	905	1,037	1,057	1,095	1,122	1,138	1,144	1,141	1,187	1,197	1,239
Change (%)		14.83	30.60	26.44	34.01	25.56	12.20	26.86	13.52	10.35	14.54	1.88	3.65	2.43	1.48	0.47	-0.27	4.08	0.84	3.47
% of Revenue	38.98	40.89	45.38	48.22	53.24	55.14	56.06	58.94	59.23	59.01	59.65	59.52	60.35	62.36	62.94	63.22	63.13	62.10	61.14	60.41

Gross Operating Profit	249	264	287	324	355	413	447	504	565	629	702	719	720	677	670	665	666	725	761	812
Change (%)		6.01	8.76	12.79	9.62	16.30	8.09	12.75	12.19	11.36	11.54	2.41	0.14	-5.91	-0.98	-0.74	0.11	8.78	5.01	6.71
% of Revenue	61.02	59.11	54.62	51.78	46.76	44.86	43.94	41.06	40.77	40.99	40.35	40.48	39.65	37.64	37.06	36.78	36.87	37.90	38.86	39.59

SG&A	162	187	202	230	253	267	284	339	390	458	513	540	556	568	597	607	623	649	671	687
Change (%)		15.72	7.98	13.65	10.14	5.66	6.23	19.33	15.07	17.49	11.91	5.35	2.94	2.06	5.25	1.69	2.58	4.18	3.33	2.44
% of Revenue	39.62	41.89	38.43	36.71	33.31	29.03	27.95	27.64	28.15	29.86	29.49	30.43	30.65	31.55	33.03	33.57	34.48	33.95	34.25	33.50

R&D
Change (%)
% of Revenue

OpEx	321	370	441	532	658	775	854	1,062	1,211	1,364	1,550	1,597	1,651	1,689	1,736	1,751	1,764	1,836	1,868	1,926
Change (%)		15.28	19.15	20.57	23.69	17.90	10.14	24.35	14.02	12.65	13.66	3.03	3.41	2.31	2.74	0.89	0.72	4.12	1.72	3.10
% of Revenue	78.59	82.78	83.81	84.93	86.55	84.17	84.01	86.58	87.38	88.87	89.14	89.96	91.00	93.92	95.96	96.80	97.62	96.05	95.39	93.91

Operating Income	87	77	85	94	102	146	163	165	175	171	189	178	163	109	73	58	43	76	90	125
Change (%)		-11.97	10.68	10.75	8.34	42.64	11.50	1.26	6.25	-2.32	10.53	-5.55	-8.36	-33.04	-33.29	-20.56	-25.72	75.39	19.44	38.46
% of Revenue	21.41	17.22	16.19	15.07	13.45	15.83	15.99	13.42	12.62	11.13	10.86	10.04	9.00	6.08	4.04	3.20	2.38	3.95	4.61	6.09

Interest Expense	-1	-1	-2	-3	-5	-8	-10	-15	-19	-23	-27	-27	-28	-26	-24	-23	-19	-20	-19	-20
Change (%)		54.71	88.11	54.68	65.30	46.32	27.80	47.08	29.07	20.07	14.25	1.80	4.83	-9.47	-5.96	-7.06	-15.81	4.71	-1.79	1.36
% of Revenue	-0.18	-0.25	-0.41	-0.53	-0.72	-0.87	-1.01	-1.23	-1.40	-1.52	-1.53	-1.53	-1.57	-1.43	-1.34	-1.24	-1.05	-1.04	-1.00	-0.96

Net Income	62	53	56	63	68	105	118	125	130	119	128	108	91	51	27	20	11	37	47	72
Change (%)		-15.20	6.65	11.59	9.47	53.73	11.98	5.81	4.66	-8.89	7.74	-15.48	-16.07	-44.10	-46.02	-25.62	-44.04	226.62	27.20	52.30
% of Revenue	15.17	11.75	10.65	9.99	9.01	11.42	11.59	10.17	9.42	7.75	7.37	6.10	5.01	2.82	1.52	1.13	0.63	1.95	2.42	3.52

Source: Capital IQ

Inter Pharma Public Company Limited - Equity Right - Income Statement (TTM)

Income Statement (TTM)